STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
MBIO MUSTANG BIO INCORPORATED StockScouter® Report
6
StockScouter® Score
MUSTANG BIO INCORPORATED, a micro cap company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
- The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
Concerns
- Moving average analysis for MBIO suggests weak price movement over the medium term. Negative
- Short-term relative price momentum exhibits meaningful weakness. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
B
C
N/A
B